NO155038C - Fremgangsmaate til fremstilling av et topisk preparat av 9- (2-hydroksy)-metyl guanin (acyclovir). - Google Patents

Fremgangsmaate til fremstilling av et topisk preparat av 9- (2-hydroksy)-metyl guanin (acyclovir).

Info

Publication number
NO155038C
NO155038C NO812464A NO812464A NO155038C NO 155038 C NO155038 C NO 155038C NO 812464 A NO812464 A NO 812464A NO 812464 A NO812464 A NO 812464A NO 155038 C NO155038 C NO 155038C
Authority
NO
Norway
Prior art keywords
acyclovir
hydroxy
preparing
procedure
topical preparation
Prior art date
Application number
NO812464A
Other languages
English (en)
Other versions
NO812464L (no
NO155038B (no
Inventor
Trevor Mervyn Jones
Alan Robert White
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26276273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO155038(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO812464L publication Critical patent/NO812464L/no
Publication of NO155038B publication Critical patent/NO155038B/no
Publication of NO155038C publication Critical patent/NO155038C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO812464A 1980-07-18 1981-07-17 Fremgangsmaate til fremstilling av et topisk preparat av 9- (2-hydroksy)-metyl guanin (acyclovir). NO155038C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8023645 1980-07-18
GB8033218A GB2080106B (en) 1980-07-18 1980-10-15 Acyclovin preparations

Publications (3)

Publication Number Publication Date
NO812464L NO812464L (no) 1982-01-19
NO155038B NO155038B (no) 1986-10-27
NO155038C true NO155038C (no) 1987-02-04

Family

ID=26276273

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812464A NO155038C (no) 1980-07-18 1981-07-17 Fremgangsmaate til fremstilling av et topisk preparat av 9- (2-hydroksy)-metyl guanin (acyclovir).

Country Status (30)

Country Link
EP (1) EP0044543B1 (no)
AR (1) AR225680A1 (no)
AT (1) AT381025B (no)
AU (1) AU547391B2 (no)
BG (1) BG60450B2 (no)
CA (1) CA1172169A (no)
CS (1) CS229674B2 (no)
CY (1) CY1309A (no)
DD (1) DD203464A5 (no)
DE (1) DE3163982D1 (no)
DK (1) DK149191C (no)
ES (1) ES8305363A1 (no)
FI (1) FI76255C (no)
GB (1) GB2080106B (no)
GR (1) GR75104B (no)
HK (1) HK95485A (no)
HU (1) HU185936B (no)
IE (1) IE51120B1 (no)
IL (1) IL63351A (no)
IT (1) IT1171399B (no)
MC (1) MC1408A1 (no)
MY (1) MY8600389A (no)
NO (1) NO155038C (no)
NZ (1) NZ197744A (no)
PH (1) PH16308A (no)
PL (1) PL135416B1 (no)
PT (1) PT73391B (no)
RO (1) RO82678A (no)
SG (1) SG72085G (no)
ZW (1) ZW17181A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
GB8602346D0 (en) * 1986-01-30 1986-03-05 Wellcome Found Antiviral combinations
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
DE69313895T2 (de) * 1992-03-20 1998-02-12 Unichema Chemie Bv Formtrennzusammensetzung
DK169121B1 (da) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
DE19517147C2 (de) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Aciclovir-Zubereitung
AU2036297A (en) * 1996-03-20 1997-10-10 Glaxo Group Limited Topical formulations of aciclovir
GB9611167D0 (en) * 1996-05-29 1996-07-31 Glaxo Group Ltd Medicaments
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
ATE396732T1 (de) * 2004-04-05 2008-06-15 Liomont S A De C V Lab Neue antivirale pharmazeutische zusammensetzung
EP2005824A1 (de) 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4049802A (en) * 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) * 1975-07-10 1979-10-24 Nyegaard & Co As Pyridthione derivatives
US4141976A (en) * 1976-01-05 1979-02-27 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE2847975A1 (de) * 1978-11-04 1980-05-14 Merck Patent Gmbh Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

Also Published As

Publication number Publication date
MY8600389A (en) 1986-12-31
CA1172169A (en) 1984-08-07
ES504046A0 (es) 1983-04-01
PH16308A (en) 1983-09-05
NO812464L (no) 1982-01-19
HK95485A (en) 1985-12-06
GR75104B (no) 1984-07-13
FI812257L (fi) 1982-01-19
CS229674B2 (en) 1984-06-18
MC1408A1 (fr) 1982-07-16
IL63351A0 (en) 1981-10-30
ES8305363A1 (es) 1983-04-01
AT381025B (de) 1986-08-11
HU185936B (en) 1985-04-28
PT73391B (en) 1983-06-15
AU547391B2 (en) 1985-10-17
PL232259A1 (en) 1983-07-04
DE3163982D1 (en) 1984-07-12
SG72085G (en) 1986-05-02
IT8148925A0 (it) 1981-07-17
IE51120B1 (en) 1986-10-01
FI76255C (fi) 1990-03-14
DK149191B (da) 1986-03-10
AU7307381A (en) 1982-01-21
IE811617L (en) 1982-01-18
ATA318081A (de) 1986-01-15
FI76255B (fi) 1988-06-30
ZW17181A1 (en) 1983-02-23
EP0044543A1 (en) 1982-01-27
PT73391A (en) 1981-08-01
AR225680A1 (es) 1982-04-15
IL63351A (en) 1983-10-31
DK149191C (da) 1986-09-08
GB2080106A (en) 1982-02-03
CY1309A (en) 1985-12-06
IT1171399B (it) 1987-06-10
GB2080106B (en) 1984-03-07
DD203464A5 (de) 1983-10-26
BG60450B2 (bg) 1995-04-28
PL135416B1 (en) 1985-10-31
RO82678A (ro) 1984-05-23
NZ197744A (en) 1983-05-10
DK321681A (da) 1982-01-19
NO155038B (no) 1986-10-27
EP0044543B1 (en) 1984-06-06

Similar Documents

Publication Publication Date Title
NO155038C (no) Fremgangsmaate til fremstilling av et topisk preparat av 9- (2-hydroksy)-metyl guanin (acyclovir).
DK43279A (da) Fremgangsmaade til fremstilling af 2-penem-3-carboxylsyreforbindelser
DK147912C (da) Fremgangsmaade til fremstilling af 1alfa-hydroxylerede vitamin d-forbindelser
NO812827L (no) Fremgangsmaate for fremstilling av et bacampicillinpreparat
DK331789A (da) Mellemprodukt til fremstilling af (s)-alpha-cyan-3-phenoxybenzylalkohol
DK520679A (da) Fremgangsmaade til fremstilling af 3-quinolincarboxulsyrederivater
DK125179A (da) Fremgangsmaade til fremstilling af disubstituerede 3-cephem-4-catboxylsyrederivater
NO792237L (no) Fremgangsmaate for fremstilling av en 7-(substituert)amino-3-substituert tiometyl-delta3-cefem-4-karboksylsyre
DK20279A (da) Fremgangsmaade til fremstilling af 4-pyridon-3-carboxylsyrederivater
DK7679A (da) Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat
DK542979A (da) Fremgangsmaade til fremstilling af et thiazolidin4-carboxylsyre-praeparat
DK331679A (da) Fremgangsmaade til fremstilling af phenylalkansyrederivater
DK257779A (da) Fremgangsmaade til fremstilling af chlor-styryl-cyclopropan-carboxylsyrederivater
NO790994L (no) Fremgangsmaate for fremstilling av et soyasapogenolderivat
NO812841L (no) Fremgangsmaate til fremstilling av florerte pentendiaminderivater
ES523320A0 (es) Procedimiento de preparacion de un derivado de acido fenoxi-benzoico bruto
DK160312C (da) Fremgangsmaade til fremstilling af derivater af 7-aminothiazolylacetamidocephalosporansyre
DK157677C (da) Fremgangsmaade til fremstilling af cyclopropancarboxylsyreesterderivater
DK130079A (da) Fremgangsmaade til fremstilling af pyridopyrimidin-derivater
DK154554C (da) Fremgangsmaade til fremstilling af alfa-methyl-carbazol-2-eddikesyrederivater
DK444279A (da) Fremgangsmaade til fremstilling af 6-hydroxymethyl-2-(beta-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylsyre
DK288079A (da) Fremgangsmaade til fremstilling af imidazolylethoxyderivater af pyrazolo (3,4-b) pyridin-5-methanoler
DK424080A (da) Fremgangsmaade til fremstilling af penicillansyrederivater
DK150879A (da) Fremgangsmaade til fremstilling af oximderivater af 3-azidomethyl-7-aminothiazolylacetamidocephalosporansyre
DK57381A (da) Fremgansmaade til fremstilling af bifenyloxypropionsyrederivater